Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Blood
|
March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma
Yan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
Nature Communications
|
January 3, 2025
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Transplantation and Cellular Therapy
|
May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma
Sarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2015
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Güllü Görgün, Mehmet K Samur, Kristen B Cowens, et al.
Leukemia
|
May 12, 2018
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing
Guangwu Guo, Noopur S Raje, Charles Seifer, et al.
Blood
|
June 10, 2025
Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment
Nicolas A Gort-Freitas, Maria Moscvin, Matteo Claudio Da Viá, et al.
American Journal of Hematology
|
November 12, 2025
The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis
Matthew J Rees, Jack Khouri, Ariel F Grajales-Cruz, et al.
Nature Methods
|
December 5, 2024
The dynamics of hematopoiesis over the human lifespan
Hojun Li, Parker Côté, Michael Kuoch, et al.
Blood Advances
|
December 3, 2024
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
Andrew J Yee, Jacob P Laubach, Erica L Campagnaro, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Medrxiv : the Preprint Server for Health Sciences
|
May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Blood
|
March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma
Yan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
Nature Communications
|
January 3, 2025
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Transplantation and Cellular Therapy
|
May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma
Sarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2015
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Güllü Görgün, Mehmet K Samur, Kristen B Cowens, et al.
Leukemia
|
May 12, 2018
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing
Guangwu Guo, Noopur S Raje, Charles Seifer, et al.
Blood
|
June 10, 2025
Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment
Nicolas A Gort-Freitas, Maria Moscvin, Matteo Claudio Da Viá, et al.
American Journal of Hematology
|
November 12, 2025
The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis
Matthew J Rees, Jack Khouri, Ariel F Grajales-Cruz, et al.
Nature Methods
|
December 5, 2024
The dynamics of hematopoiesis over the human lifespan
Hojun Li, Parker Côté, Michael Kuoch, et al.
Blood Advances
|
December 3, 2024
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
Andrew J Yee, Jacob P Laubach, Erica L Campagnaro, et al.
Page
of 10